Aurinia Pharmaceuticals is based out of Edmonton. Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics. The firm last filed a Form D notice of exempt offering of securities on 2014-02-28. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
AURINIA PHARMACEUTICALS INC.#140, 14315 - 118 AVENUE
EDMONTON A0 T5L 4S6
Business Phone: 250-744-2487
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS